Levetiracetam Aurobindo Pharma Italia (Levetiracetam)

Levetiracetam is an anticonvulsant used to treat epilepsy and related seizure disorders.

• Partial seizures: Reduces the frequency and severity of focal onset seizures.
• Generalized tonic‑clonic seizures: Helps prevent convulsive episodes in patients with generalized epilepsy.
• Myoclonic seizures: Decreases sudden muscle jerks associated with myoclonic epilepsy.

• Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This action reduces abnormal neuronal firing and lowers the likelihood of seizure propagation across the central nervous system.

Levetiracetam may cause a range of adverse reactions. Patients should be aware of both frequent and rare events.

Common Side Effects

• Dizziness: Transient sensation of light‑headedness.
• Fatigue: Generalized tiredness or lack of energy.
• Headache: Mild to moderate cranial pain.
• Irritability: Mood changes including increased agitation.
• Somnolence: Excessive sleepiness during the day.
• Nausea: Mild gastrointestinal upset.

Serious or Rare Side Effects

• Severe allergic reaction: Rash, swelling, or difficulty breathing.
• Stevens‑Johnson syndrome: Rare but life‑threatening skin eruption.
• Suicidal thoughts: New or worsening mood disturbances.
• Hematologic abnormalities: Unexplained bruising or bleeding.
• Hepatic failure: Jaundice or abnormal liver function tests.
• Acute psychosis: Hallucinations or delusional thinking.

Before initiating therapy, clinicians should consider several safety factors.

• Renal impairment: Adjust dose based on creatinine clearance.
• Mood changes: Monitor for depression, anxiety, or suicidal ideation.
• Abrupt discontinuation: Taper gradually to avoid seizure rebound.
• Elderly patients: Use lower initial doses and monitor tolerability.
• Pregnancy: Evaluate risk‑benefit ratio and consult obstetric specialist.
• Store at room temperature: Keep in the original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Carbamazepine: May lower levetiracetam plasma concentrations.
• Enzyme‑inducing antiepileptics (e.g., phenytoin, phenobarbital): Can reduce therapeutic effect.

Moderate Interactions (Monitor Closely)

• Alcohol: May enhance central nervous system depression.
• Valproate: May require monitoring of seizure control.
• Probenecid: Can affect renal excretion of levetiracetam.